Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Ugeskr Laeger ; 177(39): V03150284, 2015 Sep 21.
Artículo en Danés | MEDLINE | ID: mdl-26418640

RESUMEN

The median arcuate ligament syndrome is a rare entity and poorly described in Danish literature. The syndrome is a diagnosis of exclusion and is characterized by chronic abdominal pain, postprandial pain and weight loss. It is believed that the median arcuate ligament, being a fibrous structure of diaphragm, compresses the coeliac trunk thus causing stenosis and malperfusion of the gastrointestinal organs. Until recently, there has been some reluctance to consider intervention with revascularization or ligament release. Within the latest decade minimally invasive techniques, including laparoscopic release of the median arcuate ligament, have shown promising results.


Asunto(s)
Síndrome del Ligamento Arcuato Medio/diagnóstico , Angiografía , Humanos , Síndrome del Ligamento Arcuato Medio/diagnóstico por imagen , Síndrome del Ligamento Arcuato Medio/fisiopatología , Síndrome del Ligamento Arcuato Medio/cirugía , Ultrasonografía
2.
J Diabetes Complications ; 28(4): 517-22, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24685364

RESUMEN

AIM: To investigate whether Roux-en-Y gastric bypass surgery (RYGB) - an in vivo model for normalisation of hyperglycaemia - improves carotid intima-media thickness (IMT) in patients with type 2 diabetes (T2D)/impaired glucose tolerance (IGT) and normal glucose tolerance (NGT). METHODS: Observational prospective study, 34 obese patients (T2D (n = 14)/IGT (n = 4), and NGT (n = 16)) were investigated before and six and 12months after RYGB. RESULTS: Mean carotid IMT was significantly reduced 12months after RYGB in patients with T2D/IGT (-0.041 mm (95% CI -0.069; -0.012, p = 0.005)) but not in patients with NGT (-0.010 mm (-0.039; 0.020, p = 0.52)). The between-group difference was not significant (p=0.13). Twelve months after RYGB, patients with respectively T2D/IGT and NGT demonstrated changes in weight: -29.9 kg, p<0.001/-30.6 kg, p < 0.001, HbA1c: -0.7%, p < 0.001/-0.1%, p = 0.33, systolic blood pressure: -2 mmHg, p = 0.68/-10 mmHg, p = 0.01 and diastolic blood pressure: -8 mmHg, p = 0.003/-11 mmHg, p < 0.001. 80% of T2D patients terminated antihyperglycaemic medication. CONCLUSION: Mean carotid IMT was significantly reduced 12months after RYGB in patients with T2D/IGT which provides evidence to support that the earliest atherosclerotic changes in the arterial wall are reversible. Although numerically different from the changes observed in patients with NGT, the between-group difference was not statistically significant.


Asunto(s)
Grosor Intima-Media Carotídeo , Diabetes Mellitus Tipo 2/complicaciones , Angiopatías Diabéticas/prevención & control , Regulación hacia Abajo , Derivación Gástrica , Intolerancia a la Glucosa/complicaciones , Obesidad Mórbida/cirugía , Adolescente , Adulto , Índice de Masa Corporal , Dinamarca/epidemiología , Diabetes Mellitus Tipo 2/sangre , Angiopatías Diabéticas/complicaciones , Angiopatías Diabéticas/diagnóstico por imagen , Angiopatías Diabéticas/epidemiología , Femenino , Intolerancia a la Glucosa/sangre , Hemoglobina Glucada/análisis , Humanos , Hiperglucemia/prevención & control , Hipertensión/complicaciones , Hipertensión/epidemiología , Hipertensión/prevención & control , Masculino , Persona de Mediana Edad , Obesidad Mórbida/sangre , Obesidad Mórbida/complicaciones , Factores de Riesgo , Enfermedades Vasculares/complicaciones , Enfermedades Vasculares/diagnóstico por imagen , Enfermedades Vasculares/epidemiología , Enfermedades Vasculares/prevención & control , Pérdida de Peso , Adulto Joven
3.
Obes Res Clin Pract ; 7(4): e269-74, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24306154

RESUMEN

Experience with Roux-en-Y gastric bypass in patients with type 1 diabetes is very limited, despite an increasing prevalence of obesity also in this population. We describe changes in anthropometric measures, insulin dose, HbA1c, blood pressure, lipid status, and metabolic response to a liquid mixed meal throughout the first year after RYGB in an obese patient with type 1 diabetes. No change in HbA1c was observed, but a 48% reduction in weight-adjusted insulin dose and improvements in cardiovascular risk factors was seen 1 year after surgery. Exaggerated secretions of anorexigenic gut hormones were seen during the meals.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Diabetes Mellitus Tipo 1/cirugía , Derivación Gástrica , Células Secretoras de Insulina/citología , Insulina/administración & dosificación , Obesidad Mórbida/cirugía , Adulto , Diabetes Mellitus Tipo 1/sangre , Femenino , Humanos , Insulina/sangre , Obesidad Mórbida/sangre , Factores de Riesgo
4.
Diabetes Care ; 33(2): 375-7, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19918005

RESUMEN

OBJECTIVE: To examine after gastric bypass the effect of peroral versus gastroduodenal feeding on glucose metabolism. RESEARCH DESIGN AND METHODS: A type 2 diabetic patient was examined on 2 consecutive days 5 weeks after gastric bypass. A standard liquid meal was given on the first day into the bypassed gastric remnant and on the second day perorally. Plasma glucose, insulin, C-peptide, glucagon, incretin hormones, peptide YY, and free fatty acids were measured. RESULTS: Peroral feeding reduced 2-h postprandial plasma glucose (7.8 vs. 11.1 mmol/l) and incremental area under the glucose curve (iAUC) (0.33 vs. 0.49 mmol . l(-1) . min(-1)) compared with gastroduodenal feeding. beta-Cell function (iAUC(Cpeptide/Glu)) was more than twofold improved during peroral feeding, and the glucagon-like peptide (GLP)-1 response increased nearly fivefold. CONCLUSIONS: Improvement in postprandial glucose metabolism after gastric bypass is an immediate and direct consequence of the gastrointestinal rearrangement, associated with exaggerated GLP-1 release and independent of changes in insulin sensitivity, weight loss, and caloric restriction.


Asunto(s)
Glucemia/metabolismo , Nutrición Enteral , Derivación Gástrica , Péptido 1 Similar al Glucagón/metabolismo , Obesidad Mórbida/cirugía , Periodo Posoperatorio , Periodo Posprandial/fisiología , Área Bajo la Curva , Péptido C/sangre , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/cirugía , Ácidos Grasos no Esterificados/sangre , Glucagón/sangre , Péptido 1 Similar al Glucagón/sangre , Humanos , Incretinas/sangre , Masculino , Persona de Mediana Edad , Péptido YY/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...